☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Alvotech
Alvotech and Teva’s Simlandi (Biosimilar, Humira) Receives the US FDA’s Approval for the Treatment of Multiple Indications
February 26, 2024
Alvotech Reports Topline Results from the Study of AVT06 (Biosimilar, Eylea) for Eye Disorders
January 3, 2024
Alvotech Reports Results from the Study of AVT05, Biosimilar Candidate to Simponi and Simponi Aria (golimumab)
November 29, 2023
Alvotech and JAMP Pharma Receives Health Canada Approval for Jamteki (Biosimilar, Stelara)
November 14, 2023
Alvotech Receives Complete Response Letter from the US FDA on the BLA for AVT04 (biosimilar, ustekinumab)
October 12, 2023
Alvotech Entered into an Exclusive License Agreement with Kashiv BioSciences to Develop and Commercialize AVT23, a Proposed Biosim...
October 4, 2023
Load more...
Back to Home